PHOENIXDX® SARS-COV-2 MULTIPLEX IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of 2019-Novel Coronavirus (SARS-CoV-2) in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.


PHOENIXDX® SARS-COV-2 MULTIPLEX IVD detects the presence of 2 different and highly specific gene sequences of corona viruses and one sequence specific for human RNA serving as a human extraction control (HEC). Additionally, a non-infectious target positive control (TPC) is included. The positive control is used to confirm functionality of the assays and overall PCR performance, the human extraction control is to evaluate the quality of the RNA isolation independently from the SARS-CoV-2 assays in a different detection channel.


Download the manual here

Related projects

ViennaLab StripAssays® and RealFast™ Assays are In Vitro diagnostic kits for the detection of genetic mutations, as well as genetic predispositions, pharmacogenetics and oncology.

Atana biosensor systems are based on Quartz Crystal Microbalance (QCM) technology. Sensor surfaces allow systems to be used to study a variety of molecular interactions of different biomolecules, including proteins, nucleic acids, and cells.

CytoTrack offers breakthrough technology for the detection of Circulating Tumor Cells (CTCs).

Copyright © 2021 Bi-MEK. All rights reserved.

Copyright © 2020 Bi-MEK. All rights reserved.

Copyright © 2020 Bi-MEK. All rights reserved.